Skip to main content
Clinical Trials/NCT04189653
NCT04189653
Completed
Not Applicable

Clinical Outcomes After Implementation of Continuous Vital Sign Monitoring on the General Ward.

Radboud University Medical Center1 site in 1 country3,896 target enrollmentAugust 1, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Clinical Deterioration
Sponsor
Radboud University Medical Center
Enrollment
3896
Locations
1
Primary Endpoint
Rapid Response Team Activations
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

In 2018, continuous monitoring (CM) of 5 vital signs with a wearable device, including automated MEWS calculation within the EMR were introduced on the surgical and internal medicine ward of our hospital. Rather than taking the measurements manually, this enabled the nurses to periodically validate the continuously derived vital signs at the protocolled moments, and simultaneously get an automatically calculated MEWS reading,. Moreover, continuous vital sign monitoring provides single channel alarms and trends of the vital signs in between the regular measurement moments. Compared to periodic manual measurements and registration in the EMR, the continuous vital sign monitoring and automated MEWS calculations in the EMR may result in better identification of clinical deterioration, and may improve clinical outcome.

The primary objective of this study is to evaluate changes in total hospital and ward stay, "Total Events" during admission (rapid response team (RRT) calls and unexpected intensive care unit (uICU) admissions and deaths) after implementation of CM on the regular surgical and internal medicine wards. Secondary objective is to evaluate changes in MEWS scores at the moment of the uICU admissions, length of hospital, ward and ICU stay and the proportion of RRT calls that results in a ICU admission.

Registry
clinicaltrials.gov
Start Date
August 1, 2018
End Date
August 1, 2020
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Admission on Inclusion ward.

Exclusion Criteria

  • Opt out of file study

Outcomes

Primary Outcomes

Rapid Response Team Activations

Time Frame: During ward admission, from moment of arival on ward till discharge or transfer, average of 4 days.

Rapid Response Team Activations

Unexpected Intensive Care Unit Admissions

Time Frame: During ward admission, from moment of arival on ward till discharge or transfer, average of 4 days.

Unexpected Intensive Care Unit Admissions

Secondary Outcomes

  • Length of Stay(During ward, ICU and hospital admission, till discharge, transfer to other hospital or death. Average of 5 days.)

Study Sites (1)

Loading locations...

Similar Trials